Summit Therapeutics plc (SMMT) PT Raised to $9.80 at Bernstein SocGen Group
Tweet Send to a Friend
(Updated - June 22, 2026 9:26 AM EDT)
Bernstein SocGen Group analyst Jeffrey Walch raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Bernstein SocGen Group analyst Jeffrey Walch raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
